Substance use and mental health conditions rarely occur in isolation—yet treatment systems are still designed that way. In this RECADEMY webinar, we’ll explore why integrated care is essential, how fragmentation impacts outcomes, and what leading organizations are doing to better align treatment models with the complex realities of the patients they serve. What You’ll Learn: […]
In this RECADEMY fireside conversation, we’ll explore how advances in neuroscience are reshaping clinical thinking about opioid use disorder, and what this means for patient engagement, treatment duration, and system design across inpatient and outpatient care settings. Recognizing opioid use disorder as a chronic brain disease can have important implications for how care is delivered, […]
Recent CDC national data shows that while total drug overdose deaths have declined from their peak, synthetic opioids remain the dominant driver of opioid-related mortality. In the most recent finalized CDC national data, synthetic opioids were involved in roughly 70% of all overdose deaths and most opioid-related deaths. The efficacy of methadone and buprenorphine is well established. CDC national data and NIDA continue […]
